NCT Age Completion date Country Intervention Patients Phase
01377870 18-55 Dec.2013 Iran BM.MSC 30 I-II
01895439 18-65 Dec.2014 Jordan BM.MSC 30 I-II
01883661 18-65 Dec.2015 India BM, UC. MSC 15 -
01844957 18-50 Sep.2014 Italy BM.MSC 20 -
01364246 16-65 Dec.2014 China UC.MSC 20 I, II
01730547 18-50 Dec.2015 Sweden BM.MSC 15 I, II
01056471 >=18 June.2012 Spain AD.MSC 30 I, II
01228266 18-50 Dec.2013 Spain BM.MSC 16 II
00813969 18-55 Dec.2014 USA BM.MSC 24 -
01745783 18-50 Nov.2014 Spain BM.MSC 30 I, II
01933802 18-70 Oct.2016 USA NP-MSC 20 I
01606215 18-50 July.2015 England BM.MSC 13 -
----------- 18-50 - Canada BM.MSC 30 I, II
01453764 18-80 Dec.2014 Mexico AD.MSC 10 I, II
01932593 25-80 Sep.2015 UK BM.MSC 6 I
00927108 >=20 Dec.2011 Thailand ODP.SC 10 -
01815632 18-65 Oct.2018 UK BM 80 II
Table 4: Ongoing registered clinical trails on Stem Cell-Based Therapy in MS around the world